Structural Studies of Expressed tIK, Anti-Inflammatory Peptide
Abstract
:1. Introduction
2. Results
2.1. Expression of tIK Peptides
2.2. Isolation of KSI-Fused tIK Peptides
2.3. Purification of tIK Peptides Using HPLC
2.4. MALDI-TOF MS and CD
2.5. Solution State NMR Spectroscopy
3. Materials and Methods
3.1. Expression of tIK Peptides
3.2. Isolation of KSI-Fused tIK Peptides
3.3. Purification of tIK Peptides Using HPLC
3.4. MALDI-TOF and CD Analyses
3.5. Solution State NMR Spectroscopy
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wu, Y.; Antony, S.; Meitzler, J.L.; Doroshow, J.H. Molecular mechanisms underlying chronic inflammation-associated cancers. Cancer Lett. 2014, 345, 164–173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Arend, W.P. Cytokine imbalance in the pathogenesis of rheumatoid arthritis: The role of interleukin-1 receptor antagonist. Semin. Arthritis Rheum. 2001, 30, 1–6. [Google Scholar] [CrossRef] [PubMed]
- Dinarello, C.A. Anti-inflammatory agents: Present and future. Cell 2010, 140, 935–950. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- La Manna, S.; Di Natale, C.; Florio, D.; Marasco, D. Peptides as Therapeutic Agents for Inflammatory-Related Diseases. Int. J. Mol. Sci. 2018, 19, 2714. [Google Scholar] [CrossRef] [Green Version]
- Collins, P.E.; Grassia, G.; Colleran, A.; Kiely, P.A.; Ialenti, A.; Maffia, P.; Carmody, R.J. Mapping the interaction of B cell leukemia 3 (BCL-3) and nuclear factor κB (NF-κB) p50 identifies a BCL-3-mimetic anti-inflammatory peptide. J. Biol. Chem. 2015, 290, 15687–15696. [Google Scholar] [CrossRef] [Green Version]
- Zheng, Z.; Jiang, H.; Huang, Y.; Wang, J.; Qiu, L.; Hu, Z.; Ma, X.; Lu, Y. Corrigendum: Screening of an anti-inflammatory peptide from Hydrophis cyanocinctus and analysis of its activities and mechanism in DSS-induced acute colitis. Sci. Rep. 2016, 6, 31259. [Google Scholar] [CrossRef] [Green Version]
- La Manna, S.; Scognamiglio, P.L.; Di Natale, C.; Leone, M.; Mercurio, F.A.; Malfitano, A.M.; Cianfarani, F.; Madonna, S.; Caravella, S.; Albanesi, C.; et al. Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces. Biochimie 2017, 138, 106–115. [Google Scholar] [CrossRef]
- Tanner, M.R.; Tajhya, R.B.; Huq, R.; Gehrmann, E.J.; Rodarte, K.E.; Atik, M.A.; Norton, R.S.; Pennington, M.W.; Beeton, C. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1. 3 channel blocker HsTX1[R14A] and its PEGylated analog. Clin. Immunol. 2017, 180, 45–57. [Google Scholar] [CrossRef]
- Lee, G.; Bae, H. Anti-inflammatory applications of melittin, a major component of bee venom: Detailed mechanism of action and adverse effects. Molecules 2016, 21, 616. [Google Scholar] [CrossRef] [Green Version]
- Neilsen, W.E.; Kaye, A.D. Steroids: Pharmacology, complication, and practice delivery issues. Ochsner J. 2014, 14, 203–207. [Google Scholar]
- Fujita, T.; Kutsumi, H.; Sanuki, T.; Hayakumo, T.; Azuma, T. Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low- dose aspirin-induced gastrointestinal injuries. J. Gastroenterol. 2013, 48, 559–573. [Google Scholar] [CrossRef] [PubMed]
- McMasters, J.; Poh, S.; Lin, J.B.; Panitch, A. Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model. J. Control. Release 2017, 258, 161–170. [Google Scholar] [CrossRef] [PubMed]
- Krief, P.; Augery-Bourget, Y.; Plaisance, S.; Merck, M.F.; Assier, E.; Tanchou, V.; Billard, M.; Bouchix, C.; Jasmin, C.; Azzarone, B. A new cytokine (IK) down-regulating HLA class II: Monoclonal antibodies, cloning and chromosome localization. Oncogene 1994, 9, 3449–3456. [Google Scholar]
- Choi, S.; Park, H.L.; Jung, S.Y.; Kim, E.K.; Cho, M.L.; Min, J.K.; Moon, S.J.; Lee, S.M.; Cho, J.H.; Lee, D.H.; et al. Therapeutic Effect of Exogenous Truncated IK Protein in Inflammatory Arthritis. Int. J. Mol. Sci. 2007, 18, 1976. [Google Scholar] [CrossRef]
- Song, Y.; Kim, M.; Kim, Y. Homology modeling and optimized expression of truncated IK protein, tIK, as an anti-inflammatory peptide. Molecules 2020, 25, 4358. [Google Scholar] [CrossRef] [PubMed]
- Fosgerau, K.; Hoffmann, T. Peptide therapeutics: Current status and future directions. Drug Discov. Today 2015, 20, 122–128. [Google Scholar] [CrossRef] [Green Version]
- Otvos, L., Jr.; Wade, J.D. Current challenges in peptide-based drug discovery. Front. Chem. 2014, 2, 62. [Google Scholar] [CrossRef] [Green Version]
- Wei, L.; Zhou, C.; Su, R.; Zou, Q. PEPred-Suite: Improved and robust prediction of therapeutic peptides using adaptive feature representation learning. Bioinformatics 2019, 35, 4272–4280. [Google Scholar] [CrossRef]
- Siligardi, G.; Hussain, R. CD spectroscopy: An essential tool for quality control of protein folding. Methods Mol. Biol. 2015, 1261, 255–276. [Google Scholar] [CrossRef]
- Miles, A.J.; Janes, R.W.; Wallace, B.A. Tools and methods for circular dichroism spectroscopy of proteins: A tutorial review. Chem. Soc. Rev. 2021, 50, 8400–8413. [Google Scholar] [CrossRef]
- Greenfield, N.J. Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 2006, 1, 2876–2890. [Google Scholar] [CrossRef] [PubMed]
- Rogers, D.M.; Jasim, S.B.; Dyer, N.T.; Auvray, F.; Réfrégiers, M.; Hirst, J.D. Electronic Circular Dichroism Spectroscopy of Proteins. Chem 2019, 5, 2751–2774. [Google Scholar] [CrossRef]
- Louis-Jeune, C.; Andrade-Navarro, M.A.; Perez-Iratxeta, C. Prediction of protein secondary structure from circular dichroism using theoretically derived spectra. Proteins 2012, 80, 374–381. [Google Scholar] [CrossRef] [PubMed]
- Kim, M.; Son, J.; Song, Y.; Kim, Y. Analysis of Plant Metabolites Damaged in Chemical Accidents Using NMR Spectroscopy. Bull. Korean Chem. Soc. 2020, 41, 1099–1106. [Google Scholar] [CrossRef]
- Gasteiger, E.; Hoogland, C.; Gattiker, A.; Duvaud, S.; Wilkins, M.R.; Appel, R.D.; Bairoch, A. Protein Identification and Analysis Tools on the ExPASy Server; Humana Press: New York, NY, USA, 2005; pp. 571–607. [Google Scholar] [CrossRef]
- Bai, Y.; Chung, J.; Dyson, H.J.; Wright, P.E. Structural and dynamic characterization of an unfolded state of poplar apo-plastocyanin formed under nondenaturing conditions. Protein Sci. 2001, 10, 1056–1066. [Google Scholar] [CrossRef] [Green Version]
- Yao, J.; Chung, J.; Eliezer, D.; Wright, P.E.; Dyson, H.J. NMR Structural and Dynamic Characterization of the Acid-Unfolded State of Apomyoglobin Provides Insights into the Early Events in Protein Folding. Biochemistry 2001, 40, 3561–3571. [Google Scholar] [CrossRef]
- Dyson, H.J.; Wright, P.E. Perspective: The essential role of NMR in the discovery and characterization of intrinsically disordered proteins. J. Biomol. NMR 2019, 73, 651–659. [Google Scholar] [CrossRef]
- Schnaitman, C.A. Effect of ethylenediaminetetraacetic acid, triton X-100, and lysozyme on the morphology and chemical composition of lsolated cell walls of Escherichia coli. J. Bacteriol. 1971, 108, 553–563. [Google Scholar] [CrossRef] [Green Version]
- Franken, K.L.; Hiemstra, H.S.; van Meijgaarden, K.E.; Subronto, Y.; den Hartigh, J.; Ottenhoff, T.H.; Drijfhout, J.W. Purification of His-tagged proteins by immobilized chelate affinity chromatography: The benefits from the use of organic solvent. Protein Expr. Purif. 2000, 18, 95–99. [Google Scholar] [CrossRef]
- Block, H.; Maertens, B.; Spriestersbach, A.; Brinker, N.; Kubicek, J.; Fabis, R.; Labahn, J.; Schafer, F. Immobilized-metal affinity chromatography (IMAC) a review. Methods Enzymol. 2009, 463, 439–473. [Google Scholar] [CrossRef]
- Rodriguez, E.L.; Poddar, S.; Iftekhar, S.; Suh, K.; Woolfork, A.G.; Ovbude, S.; Pekarek, A.; Walters, M.; Lott, S.; Hage, D.S. Affinity chromatography: A review of trends and developments over the past 50 years. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2020, 1157, 122332. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kim, M.; Kim, Y. Structural Studies of Expressed tIK, Anti-Inflammatory Peptide. Int. J. Mol. Sci. 2023, 24, 636. https://doi.org/10.3390/ijms24010636
Kim M, Kim Y. Structural Studies of Expressed tIK, Anti-Inflammatory Peptide. International Journal of Molecular Sciences. 2023; 24(1):636. https://doi.org/10.3390/ijms24010636
Chicago/Turabian StyleKim, Minseon, and Yongae Kim. 2023. "Structural Studies of Expressed tIK, Anti-Inflammatory Peptide" International Journal of Molecular Sciences 24, no. 1: 636. https://doi.org/10.3390/ijms24010636